Reducing RX Costs w/ Real-Time Data: Interview with RxRevu CEO, Kyle Kiser
Kyle Kiser, CEO of RxRevu is passionate about giving providers real-time data so they can...
Read MorePosted by Stephanie | Dec 10, 2021 | Career, interview, Making Healthcare Work For You, Mission, Stephanie
Kyle Kiser, CEO of RxRevu is passionate about giving providers real-time data so they can...
Read MorePosted by Stephanie | Nov 18, 2021 | Career, interview, Making Healthcare Work For You, Mission, Stephanie
Dr. Mary O’Connor is the Co-Founder and Chief Medical Officer of Vori Health, and she’s working to transform delivery of musculoskeletal care using a holistic, integrated approach.
Dr. O’Connor says according to The WHO, musculoskeletal conditions are the number one global cause of disability. That also obviously has a huge impact on the workforce.
Read MorePosted by Stephanie | Nov 16, 2021 | Career, interview, Making Healthcare Work For You, Mission, Stephanie
Dr. Mary O’Connor is the co-founder and Chief Medical Officer of Vori Health, and she’s working to transform delivery of musculoskeletal care using a holistic, integrated approach.
In this short video, we talk about Vori, and hear from Dr. O’Connor about her background and how she sees Vori Health’s ability to make a huge impact.
Read MorePosted by Stephanie | Nov 11, 2021 | Career, interview, Making Healthcare Work For You, Mission, Stephanie
Dr. Jennifer Potter, Professor of Psychiatry & Behavior Science, and VP for Research at UT Health San Antonio is working to overhaul the treatment approach and culture around substance use.
She’s on a mission to provide compassionate, evidence-based treatment using a rational and scientific approach to reduce morbidity and mortality, while increasing access and equity.
Read MorePosted by Stephanie | Nov 9, 2021 | Career, interview, Making Healthcare Work For You, Mission, Stephanie
Dr. Besim Ogretmen of the Medical University of South Carolina recently discovered a Covid Biomarker through lipid research.
They discovered that a person’s level of lipid biomarker sphingosine had more than a 90% accuracy rate of determining if the person would have an asymptomatic or symptomatic case of covid-19.
In this interview Dr. Ogretmen shares information about his research, the discovery, as well as incredibly fascinating information about the field of Lipidomics – and how increased focus on the field could help transform medicine.
Read MoreWelcome to Speaking Of…